
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
KDM5B promotes self‐renewal of hepatocellular carcinoma cells through the microRNA‐448–mediated YTHDF3/ITGA6 axis
Juncheng Guo, Zhuo Liu, Yijun Yang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 13, pp. 5949-5962
Open Access | Times Cited: 30
Juncheng Guo, Zhuo Liu, Yijun Yang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 13, pp. 5949-5962
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins
Jingyu Liao, Yi Wei, Junnan Liang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 59
Jingyu Liao, Yi Wei, Junnan Liang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 59
A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma
Rong Zhou, Wen Ni, Chao Qin, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 40
Rong Zhou, Wen Ni, Chao Qin, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 40
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
The emerging roles of histone demethylases in cancers
Dali Tong, Ying Tang, Peng Zhong
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 2, pp. 795-821
Closed Access | Times Cited: 9
Dali Tong, Ying Tang, Peng Zhong
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 2, pp. 795-821
Closed Access | Times Cited: 9
Crosstalk between m6A modification and non-coding RNAs in HCC
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 7
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 7
The role of RNA modification in hepatocellular carcinoma
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology
Rahele Khademi, Hossein Malekzadeh, Sara Bahrami, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3466-3466
Open Access | Times Cited: 15
Rahele Khademi, Hossein Malekzadeh, Sara Bahrami, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3466-3466
Open Access | Times Cited: 15
New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma
Yujia Li, Yangling Qiu, Meng-ran Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1130-1141
Closed Access | Times Cited: 4
Yujia Li, Yangling Qiu, Meng-ran Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1130-1141
Closed Access | Times Cited: 4
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4
Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
Yasuyo Ohguchi, Hiroto Ohguchi
Cancers (2022) Vol. 14, Iss. 13, pp. 3270-3270
Open Access | Times Cited: 17
Yasuyo Ohguchi, Hiroto Ohguchi
Cancers (2022) Vol. 14, Iss. 13, pp. 3270-3270
Open Access | Times Cited: 17
Recent Advances in the Mutual Regulation of m6A Modification and Non-Coding RNAs in Atherosclerosis
Yanlu Wang, Shun M. Ling, Hao Feng, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1047-1073
Open Access
Yanlu Wang, Shun M. Ling, Hao Feng, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1047-1073
Open Access
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Network pharmacology-based identification of key pharmacological pathways of epimedium acting on hepatocellular carcinoma
Yan Mei, G. Lai, R. Xiao
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100532-100532
Open Access
Yan Mei, G. Lai, R. Xiao
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100532-100532
Open Access
Revealing tumor microenvironment communication through m6A single-cell analysis and elucidating immunotherapeutic potentials for cutaneous melanoma (CM)
Lun Liu, Maxwell Andriano Kishengere, Xueming Xu, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
Lun Liu, Maxwell Andriano Kishengere, Xueming Xu, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
Acetylated KIAA1429 by TIP60 facilitates metastasis and immune evasion of hepatocellular carcinoma via N6-methyladenosine-KDM5B-mediated regulation of FoxO1
Hu Quan, Huijun Zhou, Fei Chen, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Hu Quan, Huijun Zhou, Fei Chen, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Epigenetic mechanisms involved in hepatocellular carcinoma development and progression
Bárbara Bueloni, Maite G. Fernández‐Barrena, Matías A. Ávila, et al.
eGastroenterology (2025) Vol. 3, Iss. 2, pp. e100186-e100186
Open Access
Bárbara Bueloni, Maite G. Fernández‐Barrena, Matías A. Ávila, et al.
eGastroenterology (2025) Vol. 3, Iss. 2, pp. e100186-e100186
Open Access
LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision
Nadia Μ. Hamdy, Al-Aliaa M. Sallam, Ola Elazazy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Nadia Μ. Hamdy, Al-Aliaa M. Sallam, Ola Elazazy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Targeting m6A binding protein YTHDFs for cancer therapy
Weikun Zhang, Tingting Wu, Yue‐Jiao Zhang, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 90, pp. 117373-117373
Closed Access | Times Cited: 9
Weikun Zhang, Tingting Wu, Yue‐Jiao Zhang, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 90, pp. 117373-117373
Closed Access | Times Cited: 9
Pharmacological agents targeting drug-tolerant persister cells in cancer
Yu‐Chi Chen, Krishne Gowda, Shantu Amin, et al.
Pharmacological Research (2024) Vol. 203, pp. 107163-107163
Open Access | Times Cited: 3
Yu‐Chi Chen, Krishne Gowda, Shantu Amin, et al.
Pharmacological Research (2024) Vol. 203, pp. 107163-107163
Open Access | Times Cited: 3
Long noncoding RNA SNHG3 interacts with microRNA‐502‐3p to mediate ITGA6 expression in liver hepatocellular carcinoma
Juncheng Guo, Jianquan Zhang, Yang Xiang, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2286-2300
Open Access | Times Cited: 3
Juncheng Guo, Jianquan Zhang, Yang Xiang, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2286-2300
Open Access | Times Cited: 3
KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma
Jia Liu, Chunsheng Nie
Anti-Cancer Drugs (2022) Vol. 33, Iss. 9, pp. 840-849
Closed Access | Times Cited: 14
Jia Liu, Chunsheng Nie
Anti-Cancer Drugs (2022) Vol. 33, Iss. 9, pp. 840-849
Closed Access | Times Cited: 14
Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma
Lihua Qu, Qian Fang, Tong Yin, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2449-2467
Open Access | Times Cited: 13
Lihua Qu, Qian Fang, Tong Yin, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2449-2467
Open Access | Times Cited: 13
Modulation of gene expression by YTH domain family (YTHDF) proteins in human physiology and pathology
Aju Kisan, Ravindresh Chhabra
Journal of Cellular Physiology (2022) Vol. 238, Iss. 1, pp. 5-31
Closed Access | Times Cited: 13
Aju Kisan, Ravindresh Chhabra
Journal of Cellular Physiology (2022) Vol. 238, Iss. 1, pp. 5-31
Closed Access | Times Cited: 13